Showing 941 - 960 results of 127,517 for search '(( i e decrease ) OR ( 5 ((fold decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.64s Refine Results
  1. 941
  2. 942
  3. 943
  4. 944
  5. 945
  6. 946
  7. 947
  8. 948
  9. 949
  10. 950
  11. 951
  12. 952
  13. 953

    rVλ6Wil fibrils cause a decrease in cardiomyocytes MTT reduction without inducing cell death. by Helen P. McWilliams-Koeppen (116503)

    Published 2015
    “…(C) Cell number, quantified using crystal violet (black) did not decrease over 72 h of incubation with 1 μM rVλ6Wil fibrils despite a decrease in MMT reduction (grey; n = 3 samples per time point). …”
  14. 954

    Nasal mucociliary clearance was decreased in <i>Ttll1</i><sup>−/−</sup> mice. by Toshiyuki Iwata (419270)

    Published 2015
    “…In the <i>Ttll1</i><sup>−/−</sup> mice, a larger amount of Evans blue persisted in the nasal cavity and a lesser amount was swallowed compared with that in the wild-type (WT) mice (mean ± SEM, n = 5, *P < 0.005 by two-tailed Student's t test).…”
  15. 955
  16. 956

    <i>Nf1</i> OPG mice exhibit decreased hole poking in response to a novel holeboard apparatus. by David F. Wozniak (78177)

    Published 2013
    “…(C) <i>Nf1</i> OPG mice also showed a trend toward decreased general ambulatory activity although this difference was also not significant (p = 0.053). …”
  17. 957

    Regulatory B10 cells are augmented and the level of IL-10 expression is decreased in the spleen of AD mice. by Jieqiong Li (327149)

    Published 2015
    “…<p>(A) Representative dot-plots showing the percentage of CD5<sup>+</sup>CD19<sup>+</sup>CD1d<sup>hi</sup> B10 cells in control (n = 10) and AD mice (n = 10); (B) Bar graph depicting the percentage of CD5<sup>+</sup>CD19<sup>+</sup>CD1d<sup>hi</sup>B10 cells in control and AD mice as analyzed by flow cytometry. …”
  18. 958
  19. 959
  20. 960

    (R+S) and (R)-albuterol decrease NF-κB activity by Marcela A Ferrada (41716)

    Published 2011
    “…After transfection, (R)-albuterol (R), (S)-albuterol (S), or racemic albuterol (R+ S) were added to cells pre-activated with (ConA, 5 μg/ml) and (PMA, 100 ng/ml) (CP) and then treated with (R)-, (S)-, or (R+S)-albuterol (Fig. 6). …”